Neonatal magnesium levels and short-term outcomes following antenatal magnesium sulphate: A descriptive study from a low- and middle-income country

Blencowe H Cousens S Chou D , et al. Why focus on preterm birth? Born too soon: The global epidemiology of 15 million preterm births. Geneva: WHO, 2013.

Walani SR . Global burden of preterm birth. Int J Gynaecol Obstet 2020; 150: 31–33.

Shepherd E Salam RA Middleton P , et al. Antenatal magnesium sulphate and adverse neonatal outcomes: a systematic review and meta-analysis. PLoS Med 2019; 16: e1002988.

Chen ML . Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 2006; 45: 957–964.

Correia AL Castro C Morais JM , et al. Hypermagnesemia in preterm neonates exposed to antenatal magnesium sulfate. Minerva Pediatr (Torino) 2025; 77: 242–249.

Doyle LW Crowther CA Middleton P , et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2024; 21: CD004661.

Drassinower D Friedman AM Levin H , et al. Does magnesium exposure affect neonatal resuscitation? Am J Obstet Gynecol 2015; 213: 424.e1–424245.

Basu SK Chickajajur V Lopez V , et al. Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection. J Perinat Med 2012; 40: 185–189.